Multiple sclerosis treatment blunts SARS-CoV-2 antibody response
Crossref DOI link: https://doi.org/10.1038/s41582-021-00551-3
Published Online: 2021-08-09
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lemprière, Sarah
Text and Data Mining valid from 2021-08-09
Version of Record valid from 2021-08-09
Article History
First Online: 9 August 2021
Free to read: This content has been made available to all.